Fetal HIV Transmission Risk and Duration of Membrane Rupture

Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy

NCT00099632 ·Status: COMPLETED ·Phase: PHASE2

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

NCT00000751 ·Status: COMPLETED ·Phase: PHASE3

Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine

NCT00000828 ·Status: COMPLETED

Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

NCT01621347 ·Status: COMPLETED

HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure

NCT03642704 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns

NCT00006396 ·Status: COMPLETED ·Phase: PHASE3

A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries

NCT00341302 ·Status: COMPLETED

Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women

NCT00100867 ·Status: COMPLETED

Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study

NCT02245022 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

NCT00872872 ·Status: COMPLETED ·Phase: NA

A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies

NCT00000910 ·Status: COMPLETED

ART Readiness in HIV-infected Pregnant Women

NCT02459678 ·Status: COMPLETED ·Phase: NA

Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission

NCT00028145 ·Status: COMPLETED

Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

NCT01310023 ·Status: COMPLETED

Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women

NCT00006320 ·Status: COMPLETED ·Phase: PHASE1

HIV Testing Strategies in the Perinatal Setting

NCT00503308 ·Status: COMPLETED ·Phase: NA

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

NCT00109590 ·Status: COMPLETED ·Phase: PHASE2

Antiretroviral Drug Levels During and After Pregnancy

NCT00616252 ·Status: COMPLETED

Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission

NCT00021671 ·Status: COMPLETED ·Phase: PHASE3

Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)

NCT00000590 ·Status: COMPLETED ·Phase: PHASE3

Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP

NCT00204308 ·Status: COMPLETED ·Phase: PHASE2

One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

NCT00142337 ·Status: COMPLETED ·Phase: PHASE2

Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand

NCT00409591 ·Status: TERMINATED ·Phase: PHASE3

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

NCT00000888 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Barriers to Postpartum Care in HIV Infected Women

NCT01853917 ·Status: COMPLETED